{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:28:27Z","timestamp":1787243307125,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["#2019\u221223822"],"award-info":[{"award-number":["#2019\u221223822"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1245\/s10434-024-15457-9","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T16:24:34Z","timestamp":1716740674000},"page":"5604-5614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model"],"prefix":"10.1245","volume":"31","author":[{"given":"Francesco","family":"Fiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Langella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Conci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Serenari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ardito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cucchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia A.","family":"Zamboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mosconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Boldrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Mirarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ruzzenente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pecorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Russolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Borzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Vara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Ercolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Giuliante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cescon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Torzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4108-4832","authenticated-orcid":false,"given":"Luca","family":"Vigan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,26]]},"reference":[{"key":"15457_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13:261\u201380.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"15457_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","volume":"149","author":"MN Mavros","year":"2014","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014;149:565\u201374.","journal-title":"JAMA Surg"},{"key":"15457_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:353\u201363.","journal-title":"J Hepatol"},{"key":"15457_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S2468-1253(21)00196-5","volume":"6","author":"M Javle","year":"2021","unstructured":"Javle M, Roychowdhury S, Kelley RK, et al. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. Lancet Gastroenterol Hepatol. 2021;6:803\u201315.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"15457_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","volume":"72","author":"V Mazzaferro","year":"2020","unstructured":"Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:364\u201377.","journal-title":"J Hepatol"},{"key":"15457_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.hpb.2019.08.015","volume":"22","author":"G Torzilli","year":"2020","unstructured":"Torzilli G, Vigano L, Fontana A, et al. Oncological outcome of R1 vascular margin for mass-forming cholangiocarcinoma: a single-center observational cohort analysis. HPB Oxf. 2020;22:570\u20137.","journal-title":"HPB Oxf"},{"key":"15457_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2016.05.019","volume":"223","author":"A Doussot","year":"2016","unstructured":"Doussot A, Gonen M, Wiggers JK, et al. Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models. J Am Coll Surg. 2016;223:493\u2013505.","journal-title":"J Am Coll Surg"},{"key":"15457_CR8","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","volume":"29","author":"MC de Jong","year":"2011","unstructured":"de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29:3140\u20135.","journal-title":"J Clin Oncol"},{"key":"15457_CR9","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1245\/s10434-018-6669-1","volume":"25","author":"S Conci","year":"2018","unstructured":"Conci S, Ruzzenente A, Vigano L, et al. Patterns of distribution of hepatic nodules (single, satellites or multifocal) in intrahepatic cholangiocarcinoma: prognostic impact after surgery. Ann Surg Oncol. 2018;25:3719\u201327.","journal-title":"Ann Surg Oncol"},{"key":"15457_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.31092","volume":"72","author":"S Job","year":"2020","unstructured":"Job S, Rapoud D, Dos Santos A, et al. Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma. Hepatology. 2020;72:965\u201381.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"15457_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hep.31410","volume":"73","author":"L Fabris","year":"2021","unstructured":"Fabris L, Sato K, Alpini G, Strazzabosco M. The tumor microenvironment in cholangiocarcinoma progression. Hepatology. 2021;73(Suppl 1):75\u201385.","journal-title":"Hepatology"},{"key":"15457_CR12","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1007\/s11605-019-04111-5","volume":"23","author":"L Vigano","year":"2019","unstructured":"Vigano L, Soldani C, Franceschini B, et al. Tumor-infiltrating lymphocytes and macrophages in intrahepatic cholangiocellular carcinoma. Impact on prognosis after complete surgery. J Gastrointest Surg. 2019;23:2216\u201324.","journal-title":"J Gastrointest Surg"},{"key":"15457_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"key":"15457_CR14","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-019-04372-x","volume":"46","author":"M Sollini","year":"2019","unstructured":"Sollini M, Antunovic L, Chiti A, Kirienko M. Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics. Eur J Nucl Med Mol Imaging. 2019;46:2656\u201372.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"15457_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Vallieres M, Abdalah MA, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328\u201338.","journal-title":"Radiology"},{"key":"15457_CR16","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.3390\/cancers12102881","volume":"12","author":"F Fiz","year":"2020","unstructured":"Fiz F, Vigano L, Gennaro N, et al. Radiomics of liver metastases: a systematic review. Cancers. 2020;12:2881.","journal-title":"Cancers"},{"key":"15457_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s12072-019-09973-0","volume":"13","author":"T Wakabayashi","year":"2019","unstructured":"Wakabayashi T, Ouhmich F, Gonzalez-Cabrera C, et al. Radiomics in hepatocellular carcinoma: a quantitative review. Hepatol Int. 2019;13:546\u201359.","journal-title":"Hepatol Int"},{"key":"15457_CR18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/diagnostics12040826","volume":"12","author":"F Fiz","year":"2022","unstructured":"Fiz F, Jayakody Arachchige VS, Gionso M, et al. Radiomics of biliary tumors: a systematic review of current evidence. Diagnostics. 2022;12:826.","journal-title":"Diagnostics"},{"key":"15457_CR19","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1007\/s00330-020-06795-9","volume":"30","author":"C Mosconi","year":"2020","unstructured":"Mosconi C, Cucchetti A, Bruno A, et al. Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation. Eur Radiol. 2020;30:4534\u201344.","journal-title":"Eur Radiol."},{"key":"15457_CR20","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ac01f3","volume":"66","author":"L Xu","year":"2021","unstructured":"Xu L, Wan Y, Luo C, et al. Integrating intratumoral and peritumoral features to predict tumor recurrence in intrahepatic cholangiocarcinoma. Phys Med Biol. 2021;66:125001.","journal-title":"Phys Med Biol"},{"key":"15457_CR21","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1007\/s00330-021-07926-6","volume":"31","author":"HJ Park","year":"2021","unstructured":"Park HJ, Park B, Park SY, et al. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features. Eur Radiol. 2021;31:8638\u201348.","journal-title":"Eur Radiol"},{"key":"15457_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/jmri.28071","volume":"56","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zou X, Zhou W, et al. Multiparametric MRI-based radiomic signature for preoperative evaluation of overall survival in intrahepatic cholangiocarcinoma after partial hepatectomy. J Magn Reson Imaging. 2022;56:739\u201351.","journal-title":"J Magn Reson Imaging"},{"key":"15457_CR23","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.3390\/cancers15174204","volume":"15","author":"F Fiz","year":"2023","unstructured":"Fiz F, Rossi N, Langella S, et al. Radiomic analysis of intrahepatic cholangiocarcinoma: non-invasive prediction of pathology data: a multicenter study to develop a clinical-radiomic model. Cancers. 2023;15:4204.","journal-title":"Cancers"},{"key":"15457_CR24","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786\u20139.","journal-title":"Cancer Res"},{"key":"15457_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00261-014-0167-0","volume":"39","author":"AD Baheti","year":"2014","unstructured":"Baheti AD, Tirumani SH, Shinagare AB, et al. Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients. Abdom Imaging. 2014;39:1193\u2013201.","journal-title":"Abdom Imaging"},{"key":"15457_CR26","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. vol 1024, Berlin: Springer; 2017."},{"key":"15457_CR27","doi-asserted-by":"publisher","DOI":"10.1201\/9781420073911","volume-title":"Frailty models in survival analysis","author":"A Wienke","year":"2010","unstructured":"Wienke A. Frailty models in survival analysis. 1st edn. London: Chapman and Hall\/CRC; 2010.","edition":"1"},{"key":"15457_CR28","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00261-021-03292-5","volume":"47","author":"KP Jin","year":"2022","unstructured":"Jin KP, Sheng RF, Yang C, Zeng MS. Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC). Abdom Radiol. 2022;47:640\u201350.","journal-title":"Abdom Radiol"},{"key":"15457_CR29","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1245\/s10434-022-11717-8","volume":"29","author":"L Vigano","year":"2022","unstructured":"Vigano L, Branciforte B, Laurenti V, et al. The histopathological growth pattern of colorectal liver metastases impacts local recurrence risk and the adequate width of the surgical margin. Ann Surg Oncol. 2022;29:5515\u201324.","journal-title":"Ann Surg Oncol"},{"key":"15457_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2018-000217","volume":"5","author":"C Fern\u00e1ndez Moro","year":"2018","unstructured":"Fern\u00e1ndez Moro C, Boz\u00f3ky B, Gerling M. Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review. BMJ Open Gastroenterol. 2018;5:e000217.","journal-title":"BMJ Open Gastroenterol"},{"key":"15457_CR31","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1007\/s00259-022-05765-1","volume":"49","author":"F Fiz","year":"2022","unstructured":"Fiz F, Masci C, Costa G, et al. PET\/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival. Eur J Nucl Med Mol Imaging. 2022;49:3387\u2013400.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"15457_CR32","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1038\/s41598-021-85186-6","volume":"11","author":"K Yugawa","year":"2021","unstructured":"Yugawa K, Itoh S, Iseda N, et al. Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status. Sci Rep. 2021;11:5845.","journal-title":"Sci Rep"},{"key":"15457_CR33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1148\/radiol.2018181485","volume":"290","author":"JH Min","year":"2019","unstructured":"Min JH, Kim YK, Choi SY, et al. Intrahepatic mass-forming cholangiocarcinoma: arterial enhancement patterns at MRI and prognosis. Radiology. 2019;290:691\u20139.","journal-title":"Radiology"},{"key":"15457_CR34","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.1007\/s00330-022-08914-0","volume":"32","author":"CY Jiao","year":"2022","unstructured":"Jiao CY, Zhang H, Ji GW, et al. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study. Eur Radiol. 2022;32:8326\u201338.","journal-title":"Eur Radiol"},{"key":"15457_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00330-016-4386-3","volume":"27","author":"N Fujita","year":"2017","unstructured":"Fujita N, Asayama Y, Nishie A, et al. Mass-forming intrahepatic cholangiocarcinoma: enhancement patterns in the arterial phase of dynamic hepatic CT: correlation with clinicopathological findings. Eur Radiol. 2017;27:498\u2013506.","journal-title":"Eur Radiol"},{"key":"15457_CR36","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s13304-020-00750-5","volume":"72","author":"L Vigan\u00f2","year":"2020","unstructured":"Vigan\u00f2 L, Lleo A, Muglia R, et al. Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma. Updates Surg. 2020;72:413\u201321.","journal-title":"Updates Surg"},{"key":"15457_CR37","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1245\/s10434-020-09581-5","volume":"28","author":"R Nakanishi","year":"2021","unstructured":"Nakanishi R, Oki E, Hasuda H, et al. Radiomics texture analysis for the identification of colorectal liver metastases sensitive to first-line oxaliplatin-based chemotherapy. Ann Surg Oncol. 2021;28:2975\u201385.","journal-title":"Ann Surg Oncol"},{"key":"15457_CR38","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s13304-023-01620-6","volume":"75","author":"L Vigan\u00f2","year":"2023","unstructured":"Vigan\u00f2 L, Ammirabile A, Zwanenburg A. Radiomics in liver surgery: defining the path toward clinical application. Updates Surg. 2023;75:1387\u201390.","journal-title":"Updates Surg"},{"key":"15457_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/biomedicines11030685","volume":"11","author":"DM Goldenholz","year":"2023","unstructured":"Goldenholz DM, Sun H, Ganglberger W, Westover MB. Sample size analysis for machine learning clinical validation studies. Biomedicines. 2023;11:685.","journal-title":"Biomedicines"},{"key":"15457_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12859-023-05156-9","volume":"24","author":"D Rajput","year":"2023","unstructured":"Rajput D, Wang WJ, Chen CC. Evaluation of a decided sample size in machine learning applications. BMC Bioinform. 2023;24:48.","journal-title":"BMC Bioinform"},{"key":"15457_CR41","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1007\/s00261-019-02028-w","volume":"44","author":"Z Bodalal","year":"2019","unstructured":"Bodalal Z, Trebeschi S, Nguyen-Kim TDL, Schats W, Beets-Tan R. Radiogenomics: bridging imaging and genomics. Abdom Radiol. 2019;44:1960\u201384.","journal-title":"Abdom Radiol"},{"key":"15457_CR42","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s10278-023-00799-9","volume":"36","author":"G Costa","year":"2023","unstructured":"Costa G, Cavinato L, Fiz F, et al. Mapping tumor heterogeneity via local entropy assessment: making biomarkers visible. J Digit Imaging. 2023;36:1038\u201348.","journal-title":"J Digit Imaging"},{"key":"15457_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.20517\/ais.2023.24","volume":"3","author":"AA Gumbs","year":"2023","unstructured":"Gumbs AA, Croner R, Abu-Hilal M, et al. Surgomics and the artificial intelligence, radiomics, genomics, oncopathomics and surgomics (AiRGOS) project. Artif Intell Surg. 2023;3:180\u20135.","journal-title":"Artif Intell Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15457-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15457-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15457-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T15:02:30Z","timestamp":1722870150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15457-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,26]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["15457"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15457-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,26]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Arturo Chiti received speaker\u2019s honoraria from Advanced Accelerator Applications, General Electric Healthcare, Sirtex Medical Europe and AmGen Europe and travel grants from General Electric Healthcare and Sirtex Medical Europe. He is a member of Blue Earth Diagnostics\u2019 and Advanced Accelerator Applications\u2019 advisory boards and received scientific support in terms of a 3-year PhD fellowship from the Sanofi Genzyme. Luca Vigan\u00f2 received speaker\u2019s honoraria from Johnson & Johnson. The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}